3 research outputs found
How Biophysical Forces Regulate Human B Cell Lymphomas
Summary: The role of microenvironment-mediated biophysical forces in human lymphomas remains elusive. Diffuse large B cell lymphomas (DLBCLs) are heterogeneous tumors, which originate from highly proliferative germinal center B cells. These tumors, their associated neo-vessels, and lymphatics presumably expose cells to particular fluid flow and survival signals. Here, we show that fluid flow enhances proliferation and modulates response of DLBCLs to specific therapeutic agents. Fluid flow upregulates surface expression of B cell receptors (BCRs) and integrin receptors in subsets of ABC-DLBCLs with either CD79A/B mutations or WT BCRs, similar to what is observed with xenografted human tumors in mice. Fluid flow differentially upregulates signaling targets, such as SYK and p70S6K, in ABC-DLBCLs. By selective knockdown of CD79B and inhibition of signaling targets, we provide mechanistic insights into how fluid flow mechanomodulates BCRs and integrins in ABC-DLBCLs. These findings redefine microenvironment factors that regulate lymphoma-drug interactions and will be critical for testing targeted therapies. : Apoorva et al. report a lymphoma micro-reactor to understand biophysical factors that regulate lymphoma growth and their therapeutic responses. They describe the role of fluid forces, from lymphatics and neo-vessels, in mechanomodulation of integrin and B cell receptor signaling. These insights shed light on the heterogeneous nature of lymphomas and may allow faster translation of therapeutics. Keywords: signaling, chemotherapy, B cell receptor, fluid, shear stress, mutation, integrin, mechanomodulation, lymph node, lymphatic
Profiling Germinal Center-like B Cell Responses to Conjugate Vaccines Using Synthetic Immune Organoids
Glycoengineered bacteria have emerged as a cost-effective
platform
for rapid and controllable biosynthesis of designer conjugate vaccines.
However, little is known about the engagement of such conjugates with
naı̈ve B cells to induce the formation of germinal centers
(GC), a subanatomical microenvironment that converts naı̈ve
B cells into antibody-secreting plasma cells. Using a three-dimensional
biomaterials-based B-cell follicular organoid system, we demonstrate
that conjugates triggered robust expression of hallmark GC markers,
B cell receptor clustering, intracellular signaling, and somatic hypermutation.
These responses depended on the relative immunogenicity of the conjugate
and correlated with the humoral response in vivo. The occurrence of these mechanisms was exploited for the discovery
of high-affinity antibodies against components of the conjugate on
a time scale that was significantly shorter than for typical animal
immunization-based workflows. Collectively, these findings highlight
the potential of synthetic organoids for rapidly predicting conjugate
vaccine efficacy as well as expediting antigen-specific antibody discovery
Recommended from our members
Dissecting the treatment-naive ecosystem of human melanoma brain metastasis
Melanoma brain metastasis (MBM) frequently occurs in patients with advanced melanoma; yet, our understanding of the underlying salient biology is rudimentary. Here, we performed single-cell/nucleus RNA-seq in 22 treatment-naive MBMs and 10 extracranial melanoma metastases (ECMs) and matched spatial single-cell transcriptomics and T cell receptor (TCR)-seq. Cancer cells from MBM were more chromosomally unstable, adopted a neuronal-like cell state, and enriched for spatially variably expressed metabolic pathways. Key observations were validated in independent patient cohorts, patient-derived MBM/ECM xenograft models, RNA/ATAC-seq, proteomics, and multiplexed imaging. Integrated spatial analyses revealed distinct geography of putative cancer immune evasion and evidence for more abundant intra-tumoral B to plasma cell differentiation in lymphoid aggregates in MBM. MBM harbored larger fractions of monocyte-derived macrophages and dysfunctional TOX+CD8+ T cells with distinct expression of immune checkpoints. This work provides comprehensive insights into MBM biology and serves as a foundational resource for further discovery and therapeutic exploration